VIDEO: Photosimulation technique may be a treatment option for patients with chronic retinal detatchment

VIENNA — At the American Society of Retina Specialists meeting, Juan Arias, MD, discusses the pilot study he and his colleagues conducted at the Clinica FOSCAL in Colombia. Arias and colleagues designed treatment using Topcon’s Pascal Laser System for the treatment of patients with chronic retinal detachment caused by central serous chorioretinopathy.

NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing novel approaches for the global eye care market including revolutionary natural non-antibiotic antimicrobial products, today announced that the New York Stock Exchange has accepted NovaBay’s plan to regain compliance with the NYSE MKT’s continued listing standards. As previously disclosed, the NYSE notified the Company on April 28, 2015 that it had fall